MANAMA: Bahrain has approved a third vaccine for Covid-19.
The National Health Regulatory Authority yesterday approved the emergency use of Covishield vaccine developed by AstraZeneca in co-operation with Oxford University and manufactured by Serum Institute of India.
NHRA chief executive Dr Mariam Al Jalahma said the approval follows an in-depth study. She noted that the authority approved the emergency use licence in co-ordination with the manufacturer because it applies quality control procedures and vaccine safety and effectiveness.
To date, Bahrain has vaccinated around 150,000 individuals since December 17, with a million doses being ordered from Chinese Sinopharm and Pfizer-BioNTech.
The country offers free vaccine to its population with a choice of the available two, although supplies of Pfizer-BioNTech have been disrupted, as reported in the GDN. A vaccine developed by Johnson & Johnson is also under consideration.
&uuid=(email))